ADIAL PHARMACEUTICALS, INC. (AZR): Form 8-K/A filed 2026-08-11
- Accepted by EDGAR
- 2026-08-10 21:13 ET
- Event date
- 2026-06-11
- Accession no.
- 0001213900-26-087439
- Original filing
- SEC EDGAR filing index
Items reported
- Item 9.01: Financial Statements and Exhibits
Lists the financial statements, pro forma information and exhibits filed with the report. It almost always accompanies another Item and is rarely news on its own.
Documents
| Type | Description | Document |
|---|---|---|
| 8-K/A | AMENDMENT NO. 1 TO FORM 8-K | ea0299800-8ka1_adial.htm |
| EX-23.1 | CONSENT OF CBIZ CPA'S P.C., INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR AZ | ea029980001ex23-1.htm |
| EX-99.3 | AUDITED CONSOLIDATED FINANCIAL STATEMENTS OF AZORA THERAPEUTICS, INC. AS OF AND | ea029980001ex99-3.htm |
| EX-99.4 | UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS OF AZORA THERAPEUTICS, INC | ea029980001ex99-4.htm |
| EX-99.5 | UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION OF ADIAL PHARMACEUT | ea029980001ex99-5.htm |
This page lists what the filing reports; it does not summarize or interpret it. Read the original documents on SEC EDGAR. How to read an 8-K.